↓ Skip to main content

Principles of Safety Pharmacology

Overview of attention for book
Cover of 'Principles of Safety Pharmacology'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 A Historical View and Vision into the Future of the Field of Safety Pharmacology
  3. Altmetric Badge
    Chapter 2 In Vitro Early Safety Pharmacology Screening: Perspectives Related to Cardiovascular Safety
  4. Altmetric Badge
    Chapter 3 Safety Pharmacology in Drug Discovery and Development
  5. Altmetric Badge
    Chapter 4 CNS Adverse Effects: From Functional Observation Battery/Irwin Tests to Electrophysiology
  6. Altmetric Badge
    Chapter 5 Preclinical Abuse Potential Assessment
  7. Altmetric Badge
    Chapter 6 Overview of Respiratory Studies to Support ICH S7A
  8. Altmetric Badge
    Chapter 7 Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist
  9. Altmetric Badge
    Chapter 8 Sensitivity and Specificity of the In Vitro Guinea Pig Papillary Muscle Action Potential Duration for the Assessment of Drug-Induced Torsades De Pointes Liability in Humans
  10. Altmetric Badge
    Chapter 9 Haemodynamic Assessment in Safety Pharmacology
  11. Altmetric Badge
    Chapter 10 High Definition Oscillometry: Non-invasive Blood Pressure Measurement and Pulse Wave Analysis
  12. Altmetric Badge
    Chapter 11 The Safety Pharmacology of Auditory Function
  13. Altmetric Badge
    Chapter 12 Principles of Safety Pharmacology
  14. Altmetric Badge
    Chapter 13 Principles of Safety Pharmacology
  15. Altmetric Badge
    Chapter 14 Inclusion of Safety Pharmacology Endpoints in Repeat-Dose Toxicity Studies
  16. Altmetric Badge
    Chapter 15 Safety Pharmacology Evaluation of Biopharmaceuticals.
  17. Altmetric Badge
    Chapter 16 Safety Pharmacology of Anticancer Agents
  18. Altmetric Badge
    Chapter 17 Clinical ECG Assessment
Attention for Chapter 3: Safety Pharmacology in Drug Discovery and Development
Altmetric Badge

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Safety Pharmacology in Drug Discovery and Development
Chapter number 3
Book title
Principles of Safety Pharmacology
Published in
Handbook of experimental pharmacology, January 2015
DOI 10.1007/978-3-662-46943-9_3
Pubmed ID
Book ISBNs
978-3-66-246942-2, 978-3-66-246943-9
Authors

Bruce H. Morimoto, Erin Castelloe, Anthony W. Fox, Morimoto, Bruce H., Castelloe, Erin, Fox, Anthony W.

Abstract

Safety pharmacology is essential throughout the spectrum of drug discovery and development. Prior to first-in-human studies, safety pharmacology assays, tests, and models predict the clinical risk profile of a potential new drug. During clinical development, safety pharmacology can be used to explore-and potentially explain-both predicted and unpredicted side effects (e.g., adverse events, changes in vital signs, abnormal laboratory values) in order to refine the original clinical risk profile. This chapter will introduce the reader to safety pharmacology's role in translational medicine: the science of translating potential drugs' on- and off-target nonclinical properties to clinical consequences in order to select the best drug candidates to move into early clinical testing. Case studies will be used to illustrate the importance of safety pharmacology testing throughout all phases of drug development.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 21%
Student > Bachelor 6 13%
Student > Master 5 10%
Student > Doctoral Student 5 10%
Student > Ph. D. Student 3 6%
Other 9 19%
Unknown 10 21%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 9 19%
Chemistry 6 13%
Biochemistry, Genetics and Molecular Biology 6 13%
Agricultural and Biological Sciences 4 8%
Medicine and Dentistry 4 8%
Other 9 19%
Unknown 10 21%